A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: Are these procedures becoming obsolete?

Annals of Surgical Oncology

Volumn 19, Issue 1, 2012, Pages 225-232

  Weber, Walter P ^a,b   Barry, Mitchel ^a   Stempel, Michelle M ^a   Junqueira, Manuela J ^a   Eaton, Anne A ^a   Patil, Sujata M ^a   Morrow, Monica ^a   Cody III, Hiram S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; REVIEW; SENTINEL LYMPH NODE BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CHILD; FEMALE; FOLLOW-UP STUDIES; FROZEN SECTIONS; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS; YOUNG ADULT;

EID: 84856660271     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1823-z     Document Type: Review

References (20)

1. T Kim AE Giuliano GH Lyman 2006 Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma Cancer 106 4 16 16329134 10.1002/cncr.21568
2. U Veronesi G Viale G Paganelli, et al. 2010 Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study Ann Surg 251 595 600 20195151 10.1097/SLA.0b013e3181c0e92a
3. DN Krag SJ Anderson TB Julian, et al. 2007 Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 881 888 17851130 10.1016/S1470-2045(07)70278-4 1:CAS:528:DC%2BD2sXhtFektbzM
4. RE Mansel L Fallowfield M Kissin, et al. 2006 Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial J Natl Cancer Inst 98 599 609 16670385 10.1093/jnci/djj158
5. G Zavagno GL De Salvo G Scalco, et al. 2008 A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial Ann Surg 247 207 213 18216523 10.1097/SLA.0b013e31812e6a73
6. G Gill 2009 Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial Ann Surg Oncol 16 266 275 19050973 10.1245/s10434-008-0229-z
7. BJ O'Hea ADK Hill A El-Shirbiny, et al. 1998 Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center J Am Coll Surg 186 423 427 9544956 10.1016/S1072-7515(98)00060-X
8. SW Chan KA Lavigne ER Port, et al. 2008 Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer? Ann Surg 247 143 149 18156934 10.1097/SLA.0b013e3181581f41
9. E Brogi E Torres-Matundan LK Tan, et al. 2005 The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients Ann Surg Oncol 12 173 180 15827799 10.1245/ASO.2005.03.067
10. SA McLaughlin LM Ochoa-Frongia SM Patil, et al. 2008 Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy J Am Coll Surg 206 76 82 18155571 10.1016/j.jamcollsurg.2007.07.021
11. KJ Van Zee DM Manasseh JL Bevilacqua, et al. 2003 A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 10 1140 1151 14654469 10.1245/ASO.2003.03.015
12. J Park JV Fey AM Naik, et al. 2007 A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram Ann Surg 245 462 468 17435554 10.1097/01.sla.0000250439.86020.85
13. MS Pugliese AK Karam M Hsu, et al. 2010 Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer Ann Surg Oncol 17 1063 1068 20033325 10.1245/s10434-009-0834-5
14. KY Bilimoria DJ Bentrem NM Hansen, et al. 2009 Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer J Clin Oncol 27 2946 2953 19364968 10.1200/JCO.2008.19.5750
15. AE Giuliano L McCall P Beitsch, et al. 2010 Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg 252 426 433 20739842
16. AE Giuliano KK Hunt KV Ballman, et al. 2011 Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA 305 569 575 21304082 10.1001/jama.2011.90 1:CAS:528:DC%2BC3MXhvVymtrg%3D
17. HS Cody PI Borgen 1999 State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center Surg Oncol 8 85 91 10732960 10.1016/S0960-7404(99)00029-8
18. IM van der Ploeg OE Nieweg MC van Rijk, et al. 2008 Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature Eur J Surg Oncol 34 1277 1284 18406100 10.1016/j.ejso.2008.01.034
19. EJ Rutgers 2008 Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases J Clin Oncol 26 698 702 18258976 10.1200/JCO.2007.14.4667
20. ME Straver P Meijnen TG van, et al. 2010 Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer J Clin Oncol 28 731 737 20038733 10.1200/JCO.2008.21.7554